Was mass spectrometry the right technique to screen large populations?
06/17/21 • 32 min
No one really knew whether mass spectrometry was up to the task of population screening. Could the instruments cope with the tens-of-thousands of dried blood spots that needed to be analyzed every year? In the mid 1990s, Dr. Mike Morris began working with newborn screening labs around the world to try and answer these questions.
No one really knew whether mass spectrometry was up to the task of population screening. Could the instruments cope with the tens-of-thousands of dried blood spots that needed to be analyzed every year? In the mid 1990s, Dr. Mike Morris began working with newborn screening labs around the world to try and answer these questions.
Previous Episode
The application of tandem mass spectrometry to NBS for amino acids and acylcarnitines - An interview with David Millington
For the 30 years following Dr. Robert Guthrie's invention of a PKU screening test newborn screening tests were limited in number. That all changed when biochemists at Duke University first applied tandem mass spectrometry to solve a puzzling clinical case. The result changed the way the newborn screening community thought about adding new screening tests.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/renata-newborn-screening-podcast-425730/was-mass-spectrometry-the-right-technique-to-screen-large-populations-58657497"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to was mass spectrometry the right technique to screen large populations? on goodpods" style="width: 225px" /> </a>
Copy